NCT07093398View on ClinicalTrials.gov

A Phase 1 Study to Assess Food Effect on the Pharmacokinetics of D3S-001 in Healthy Adult Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 11, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

January 30, 2026

Conditions

Healthy Adult Volunteers

Interventions

DRUG

D3S-001

"The investigational product dose: 600 mg D3S-001 capsules.~A 600-mg oral dose of D3S-001 will be given to potential participants on Day 1 and Day 4."

Trial Locations (2)

5000

RECRUITING

CMAX Clinical Research, Adelaide

RECRUITING

CMAX Clinical Research, Adelaide